As Glaucoma Awareness Month highlights evolving practice, specialists describe how artificial intelligence, sustained drug ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Failure of the Paul Glaucoma Implant occurred in 8% of ...

Two years ago, the 3-year results of the Ahmed Baerveldt Comparison (ABC) were released. For further follow-up, the study group is presenting the 5-year outcomes. A total of 276 patients initially ...

Joel S. Schuman, MD, FACS, highlights home tonometry, virtual visual fields, and portable OCT devices as promising tools, ...

Late-stage neovascular glaucoma can require surgical management, typically with a glaucoma drainage implant, but treatment should be individualized depending on patient factors, according to a speaker ...

Glaucoma typically occurs when a blockage in the eye's drainage channels causes aqueous humor fluid to accumulate within the eye faster than it can drain out. This increases intraocular pressure, ...

Glaucoma, which affects an estimated 57 million people worldwide, is an eye condition caused by too much pressure around the eye, which can damage the optical nerve and lead to irreversible blindness.

Several biodegradable sustained-release (SR) device concepts, from drug-eluting contact lenses to lacrimal inserts and intracameral implants, have been put forward in recent years as a means of ...

Bausch + Lomb has partnered with the glaucoma community once again, launching its fifth annual fundraising challenge and ...

Glaucoma is a blinding disease caused by damage to the optic nerve, leading to permanent vision loss. The main risk factor is ...